Sakar Healthcare Ltd (SAKAR) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Part of MojoOne Strategy

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Fredun Pharma

NGL Fine Chem

Venus Remedies

Sakar Healthcare

Windlas Biotech

Ind-Swift Labs.

Shukra Pharma.

Hester Bios

Indoco Remedies

Fermenta Biotec.

Sai Parenteral's

Why is Sakar Healthcare Ltd ?

With a growth in Net Profit of 120.13%, the company declared Very Positive results in Jun 26

The company has declared positive results for the last 7 consecutive quarters
OPERATING PROFIT TO INTEREST(Q) Highest at 12.72 times
PBT LESS OI(Q) At Rs 13.04 cr has Grown at 161.32%
PAT(Q) At Rs 10.28 cr has Grown at 120.1%

With ROCE of 11.9, it has a Very Expensive valuation with a 5.5 Enterprise value to Capital Employed

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -100.00%, its profits have risen by 82.3% ; the PEG ratio of the company is 0.7

High Institutional Holdings at 23.51%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Below par performance in long term as well as near term

Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Sakar Healthcare should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sakar Healthcare for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sakar Healthcare

175.27%

3.41

51.44%

Sensex

-1.65%

-0.12

13.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

21.00%

EBIT Growth (5y)

28.29%

EBIT to Interest (avg)

4.42

Debt to EBITDA (avg)

2.13

Net Debt to Equity (avg)

0.17

Sales to Capital Employed (avg)

0.53

Tax Ratio

26.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

23.51%

ROCE (avg)

7.95%

ROE (avg)

7.85%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.20

EV to EBIT

39.10

EV to EBITDA

26.71

EV to Capital Employed

5.45

EV to Sales

7.60

PEG Ratio

0.70

Dividend Yield

ROCE (Latest)

11.95%

ROE (Latest)

9.39%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

30What is working for the Company

OPERATING PROFIT TO INTEREST(Q)

Highest at 12.72 times

PBT LESS OI(Q)

At Rs 13.04 cr has Grown at 161.32%

PAT(Q)

At Rs 10.28 cr has Grown at 120.1%

ROCE(HY)

Highest at 12.54%

DEBT-EQUITY RATIO(HY)

Lowest at 0.17 times

NET SALES(Q)

At Rs 72.97 cr has Grown at 38.36%

-4What is not working for the Company

INTEREST(Latest six months)

At Rs 4.08 cr has Grown at 23.26%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.03 times

Loading Valuation Snapshot...

Here's what is working for Sakar Healthcare

Operating Profit to Interest - Quarterly

Highest at 12.72 times and Grown

each quarter in the last five quarters

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 13.04 cr has Grown at 161.32%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 10.28 cr has Grown at 120.1%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly

Highest at Rs 72.97 cr and Grown

each quarter in the last five quarters

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly

At Rs 72.97 cr has Grown at 38.36%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly

Lowest at 0.17 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Sakar Healthcare

Interest - Latest six months

At Rs 4.08 cr has Grown at 23.26%

over previous Half yearly period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debtors Turnover Ratio- Half Yearly

Lowest at 5.03 times

in the last five half yearly periods

MOJO Watch

Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly

Highest at Rs 1.54 cr

in the last five quarters

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating Income